Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$69.63 USD
+1.50 (2.20%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $69.65 +0.02 (0.03%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
EW 69.63 +1.50(2.20%)
Will EW be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for EW based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EW
Edwards Lifesciences to Report Q3 Earnings: What's in the Cards?
TFX vs. EW: Which Stock Is the Better Value Option?
EW: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is it the Right Time to Hold EW Stock in Your Portfolio Now?
TFX vs. EW: Which Stock Should Value Investors Buy Now?
Why Is Globus Medical (GMED) Down 0.2% Since Last Earnings Report?
Other News for EW
December 13, 2024 Deadline: Contact Levi & Korsinsky LLP to Join Class Action Suit Against EW
Analysts Conflicted on These Healthcare Names: Allakos (ALLK), Edwards Lifesciences (EW) and NewAmsterdam Pharma Company (NAMS)
Edwards Lifesciences resumed with an Equal Weight at Morgan Stanley
Edwards Lifesciences Corp (EW) Stock Price Up 6.14% on Oct 8
Edwards Lifesciences call volume above normal and directionally bullish